Bifunctional solid catalysts for chemoselective hydrogenation-cyclisation- amination cascade reactions of relevance for the synthesis of pharmaceuticals

Tetrahedron

Volumn 66, Issue 41, 2010, Pages 8203-8209

  Leyva Pérez, Antonio ^a   Cabrero Antonino, Jose R ^a   Corma, Avelino ^a  

^a CSIC   (Spain)

Author keywords

Antipsychotics; Cascade reactions; Clozapine; Heterogeneous catalysis; Olanzapine

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; TIN CHLORIDE;

AMINATION; ARTICLE; CATALYSIS; CHEMICAL REACTION; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGENATION; LEACHING; ONE POT SYNTHESIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REACTION ANALYSIS; STOICHIOMETRY;

EID: 77956617269     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2010.08.022     Document Type: Article

References (42)

1. K.C. Nicolaou, and S.A. Snyder Classics in Total Synthesis II: More Targets, strategies, Methods Vol. 2 2003 Wiley-VCH Weinheim pp 560
2. K.C. Nicolaou, and E.J. Sorensen Classics in Total Synthesis II: Targets, Strategies, Methods 1996 Wiley-VCH Weinheim pp 798
3. I.R. Baxendale, J.J. Hayward, S. Lanners, S.V. Ley, and C.D. Smith T. Wirth, Microreactors in Organic Synthesis and Catalysis 2008 Wiley-VCH Weinheim 84 122
4. I.R. Baxendale, and S.V. Ley Ernst Schering Foundation Symposium Proceedings 2006-3 2007 Springer Berlin, Heidelberg 151-185
5. See also: J.M. Thomas, and R. Raja Stud. Surf. Sci. Catal. 170A 2007 19 40
6. V.R. Ruiz, A. Corma, and M.J. Sabater Tetrahedron 66 2010 730 735
7. M.J. Climent, A. Corma, S. Iborra, and L.L. Santos Chem. - Eur. J. 15 2009 8834 8841
8. A. Corma, and M. Renz Angew. Chem., Int. Ed. 46 2007 298 300
9. For examples on solid-phase synthesis of natural products see S.V. Ley, I.R. Baxendale, R.N. Bream, P.S. Jackson, A.G. Leach, D.A. Longbottom, M. Nesi, J.S. Scott, R.I. Storer, and S.J. Taylor J. Chem. Soc., Perkin Trans. 1 2000 3815 4195
10. J. Nielsen Curr. Op. Chem. Biol. 6 2002 297 305
11. M. Beller Ernst Schering Foundation Symposium Proceedings 2006-3 2007 Springer Berlin, Heidelberg pp 99-116
12. A. Corma Catal. Rev. Sci. Eng. 46 2004 369 417
13. C. Copéret New J. Chem. 28 2004 1 10
14. M. Boronat, M.J. Climent, A. Corma, S. Iborra, R. Monton, and M.J. Sabater Chem. - Eur. J. 16 2010 1221 1231
15. A. Corma, and P. Serna Science 313 2006 332 334
16. R. Juárez, P. Concepción, A. Corma, V. Fornés, and H. García Angew. Chem., Int. Ed. 49 2010 1286 1290
17. A. Corma, P. Serna, P. Concepcion, and J.J. Calvino J. Am. Chem. Soc. 130 2008 8748 8753
18. For a very recent paper on the genetic component of schizophrenia, see L. Citrome Int. J. Clin. Pract. 63 2009 140 150
19. O. Fazzari, A.V. Paternain, M. Valiente, R. Pla, R. Luján, K. Lloyd, J. Lerma, O. Marín, and B. Rico Nature 2010 10.1038/nature08928 published online 14 April
20. Chakrabarti, J.K, Hotten, T.M, Tupper, D.E, Eli Lilly & Industries Limited: USA, 1993; Vol. US005229382A, p 6.
21. The patent for 1 expires in 2011 and no patent applies for 2 yet.
22. For impurities and degradation products see Shastri, J.A, Bhatnagar, A, Thaper, R.K, Dubey, S.K, Jubilant Organosys Limited: USA, 2006; Vol. WO 2006/006180 A1, p 18.
23. P. Thatipalli, R. Kumar, C. Bulusu, R. Chakka, P.R. Padi, A. Yerra, and S. Bollikonda ARKIVOC 11 2008 195 201
24. S.W. Baertschi, H. Brunner, C.A. Bunnell, G.G. Cooke, B. Diseroad, D.E. Dorman, P.J. Jansen, C.A.J. Kemp, S.R. Maple, K.A. Mccune, and J.L. Speakman J. Pharm. Sci. 97 2008 883 892
25. V.P. Shevchenko, I.Y. Nagaev, Y.V. Kuznetsov, E.V. Polunin, A.A. Zozulya, and N.F. Myasoedov Russ. J. Bioorg. Chem. 31 2005 378 382
26. 2 is a standard method for reduction of nitro compounds.
27. 3 catalysts see: K. Balázsik, K. Szöri, K. Felföldi, B. Török, and M. Bartók Chem. Commun. 2000 555 556
28. A. Corma, V. Fornes, M.T. Navarro, and J. Perez-Pariente J. Catal. 148 1994 569 574
29. A. Corma, H. García, and A. Leyva Tetrahedron 60 2004 8553 8560
30. H. Kosslick, G. Lischke, B. Parlitz, W. Storek, and R. Fricke Appl. Catal., A 184 1999 49 60
31. 2 see: F.R. Chen, G. Coudurier, J.-F. Joly, and J.C. Vedrine J. Catal. 143 1993 616 626
32. B.M. Reddy, P.M. Sreekanth, and V.R. Reddy J. Mol. Cat. A 225 2005 71 78
33. A. Corma, V. Fornes, J.M. Guil, S. Pergher, T.L.M. Maesen, and J.G. Buglass Micropor. Mesopor. Mater. 38 2000 301 309
34. U. Diaz, V. Fornes, and A. Corma Micropor. Mesopor. Mater. 90 2006 73 80
35. 2 act as chemoselective hydrogenation catalyst for nitrobenzenes, see Refs. 6 and 7 and also:
36. M. Boronat, P. Concepción, A. Corma, S. González, F. Illas, and P. Serna J. Am. Chem. Soc. 129 2007 16230 16237
37. A. Corma, P. Concepción, and P. Serna Angew. Chem., Int. Ed. 46 2007 7266 7269
38. A. Corma, P. Serna, and H. García J. Am. Chem. Soc. 129 2007 6358 6359
39. T.K. Sasikumar, D.A. Burnett, H. Zhang, A. Smith-Torhan, A. Fawzi, and J.E. Lachowicz Bioorg. Med. Chem. Lett. 16 2006 4543 4547
40. J. Su, H. Tang, B.A. McKittrick, D.A. Burnett, H. Zhang, A. Smith-Torhan, A. Fawzi, and J. Lachowicz Bioorg. Med. Chem. Lett. 16 2006 4548 4553
41. T. de Paulis, D.A. Davis, H.E. Smith, D.H. Malarek, and A.A. Liebman J. Labelled Compd. Radiopharm. 25 1988 1027 1033
42. H. Matloubi, M. Ghandi, M.-R. Zarrindast, and N. Saemian Appl. Radiat. Isot. 55 2001 789 791